Michael S. Kellogg
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael S. Kellogg.
Tetrahedron Letters | 1979
Jules A. Aimetti; Ernest Seiichi Hamanaka; David A. Johnson; Michael S. Kellogg
Abstract Reduction of 6-substituted-6-halopenicillanates with tri-n-butyltin hydride can produce stereoselectively 6β-substituted derivatives.
Tetrahedron Letters | 1979
Jules A. Aimetti; Michael S. Kellogg
Abstract Unique stereocontrol in aldolization at C6 of penicillanates through modification of solvent and cation has been observed.
Tetrahedron Letters | 1991
V. John Jasys; Michael S. Kellogg; Robert A. Volkmann
Abstract Novel sulfenamide-containing [3,2,0]bicyclic β-lactams, which are potent inhibitors of human leukocyte elastase, were prepared.
Bioorganic & Medicinal Chemistry Letters | 1993
W. Stephen Faraci; Alice V. Bakker; Robin W. Spencer; Rebecca Williams; V. John Jasys; Michael S. Kellogg; Robert A. Volkmann
Abstract Novel 3,2,0 bicyclic β-lactam sulfenamides and selected carbon isosteres are inhibitors of human leukocyte elastase. The comparative biological activity and hydrolytic stability of these compounds are described.
Archive | 1979
Michael S. Kellogg
The Journal of Antibiotics | 1990
Thomas D. Gootz; Dennis Girard; William Schelkley; Thomas G. Tensfeldt; George Foulds; Michael S. Kellogg; John G. Stam; Benedict Campbell; John Jasys; Paul R. Kelbaugh; Robert A. Volkmann; Ernest Seiichi Hamanaka
Archive | 1979
Michael S. Kellogg; Ernest Seiichi Hamanaka
Archive | 1985
Michael S. Kellogg
Archive | 1980
Michael S. Kellogg
Archive | 1982
Vytautas John Jasys; Michael S. Kellogg